Effect of Erenumab on Absenteeism and Presenteeism in Patients with Episodic and Chronic Migraine in Actual Clinical Practice in Japan: A Retrospective Observational Study

被引：0
|
作者：
Sadamoto, Yasutaka [1 ]
机构：
[1] Takanoko Hosp, Matsuyama, Ehime, Japan
来源：
CEPHALALGIA | 2023年 / 43卷 / 1supp期
关键词：
D O I：
暂无
中图分类号：
R74 [神经病学与精神病学];
学科分类号：
摘要：
IHC23-PO-2
引用
收藏
页码：225 / 225
页数：1
相关论文
共 50 条
  • [1] Evaluation of the effect of erenumab on migraine-specific questionnaire in patients with chronic and episodic migraine
    Chen, Po-Wei
    Karlsson, Mats O.
    Ueckert, Sebastian
    Pritchard-Bell, Ari
    Hsu, Cheng-Pang
    Dutta, Sandeep
    Ahamadi, Malidi
    CPT-PHARMACOMETRICS & SYSTEMS PHARMACOLOGY, 2023, 12 (12): : 1988 - 2000
  • [2] Effectiveness and safety of erenumab and galcanezumab in the prevention of chronic and episodic migraine: A retrospective cohort study
    Viudez-Martinez, Adrian
    Pascual-Carrasco, Angela
    Beltran-Blasco, Isabel
    Hernandez-Lorido, Raquel
    de Apodaca, Rosa F. Ruiz
    JOURNAL OF CLINICAL PHARMACY AND THERAPEUTICS, 2022, 47 (06) : 814 - 823
  • [3] Pooled retrospective analysis of 70 mg erenumab in episodic and chronic migraine: a two tertiary headache centers experience during clinical practice
    P. Storch
    P. Burow
    B. Möller
    T. Kraya
    S. Heintz
    N. Politz
    S. Naegel
    Acta Neurologica Belgica, 2022, 122 : 931 - 937
  • [4] Pooled retrospective analysis of 70 mg erenumab in episodic and chronic migraine: a two tertiary headache centers experience during clinical practice
    Storch, P.
    Burow, P.
    Moller, B.
    Kraya, T.
    Heintz, S.
    Politz, N.
    Naegel, S.
    ACTA NEUROLOGICA BELGICA, 2022, 122 (04) : 931 - 937
  • [5] Effect of erenumab on the reversion from chronic migraine to episodic migraine in an Asian population: A post hoc analysis of the DRAGON study
    Wang, Shuu-Jiun
    Kim, Byung-Kun
    Wang, Hebo
    Zhou, Jiying
    Wan, Qi
    Yu, Tingmin
    Lian, Yajun
    Arkuszewski, Michal
    Ecochard, Laurent
    Snellman, Josefin
    Wen, Shihua
    Yin, Fangfang
    Li, Zheng
    Su, Wendy
    Yu, Shengyuan
    HEADACHE, 2025, 65 (01): : 143 - 152
  • [6] Clinical characteristics and patient-reported outcomes of chronic and episodic migraine patients at a US tertiary headache center: A retrospective observational study
    Ahmed, Zubair
    Honomichl, Ryan
    Thompson, Stephen F.
    Cohen, Joshua M.
    Schuster, Andrew
    Thompson, Nicolas R.
    Lapin, Brittany
    Udeh, Belinda L.
    Campos, Verena Ramirez
    Krasenbaum, Lynda J.
    Katzan, Irene L.
    HEADACHE, 2023, 63 (07): : 908 - 916
  • [7] Dual therapy with Erenumab and onabotulinumtoxinA: No synergistic effect in chronic migraine: A retrospective cohort study
    Jaimes, Alex
    Gomez, Andrea
    Pajares, Olga
    Rodriguez-Vico, Jaime
    PAIN PRACTICE, 2023, 23 (04) : 349 - 358
  • [8] Effectiveness of erenumab in chronic migraine patients with associated medication overuse headache: a prospective observational study
    Curone, Marcella
    Tullo, Vincenzo
    Bussone, Gennaro
    NEUROLOGICAL SCIENCES, 2020, 41 (SUPPL 2) : 509 - 510
  • [9] Real-world persistence of erenumab for preventive treatment of chronic and episodic migraine: Retrospective real-world study
    Gladstone, Jonathan
    Chhibber, Sameer
    Minhas, Jagdeep
    Neish, Calum S.
    Power, G. Sarah
    Lan, Zhiyi
    Rochdi, Driss
    Lanthier-Martel, Jessica
    Bastien, Natacha
    HEADACHE, 2022, 62 (01): : 78 - 88
  • [10] Effectiveness of erenumab in chronic migraine patients with associated medication overuse headache: a prospective observational study
    Marcella Curone
    Vincenzo Tullo
    Gennaro Bussone
    Neurological Sciences, 2020, 41 : 509 - 510
12345